Brian P Brennan

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Intensive residential treatment for severe obsessive-compulsive disorder: Characterizing treatment course and predictors of response
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA Obsessive Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA Department of Psychiatry, Harvard Medical School, Boston, MA, USA Electronic address
    J Psychiatr Res 56:98-105. 2014
  2. doi request reprint A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 33:627-35. 2013
  3. pmc Performance-enhancing drugs on the web: a growing public-health issue
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Am J Addict 22:158-61. 2013
  4. pmc A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Biol Psychiatry 73:24-31. 2013
  5. doi request reprint Memantine in the treatment of binge eating disorder: an open-label, prospective trial
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 41:520-6. 2008
  6. pmc Human growth hormone abuse in male weightlifters
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Am J Addict 20:9-13. 2011
  7. pmc Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Neuropsychopharmacology 35:834-46. 2010
  8. ncbi request reprint Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Hum Psychopharmacol 24:423-8. 2009
  9. ncbi request reprint Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 30:126-34. 2010
  10. doi request reprint Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development
    Andrew A Nierenberg
    Massachusetts General Hospital, Boston, MA 02114, USA
    Aust N Z J Psychiatry 47:26-42. 2013

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Intensive residential treatment for severe obsessive-compulsive disorder: Characterizing treatment course and predictors of response
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA Obsessive Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA Department of Psychiatry, Harvard Medical School, Boston, MA, USA Electronic address
    J Psychiatr Res 56:98-105. 2014
    ..Intensive residential treatment (IRT) is effective for severe, treatment-resistant obsessive-compulsive disorder (OCD). We sought to characterize predictors and course of response to IRT...
  2. doi request reprint A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 33:627-35. 2013
    ....
  3. pmc Performance-enhancing drugs on the web: a growing public-health issue
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Am J Addict 22:158-61. 2013
    ..We attempted to qualitatively characterize APED-related Internet sites...
  4. pmc A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Biol Psychiatry 73:24-31. 2013
    ..We conclude with suggestions for possible future proton magnetic resonance spectroscopy studies in OCD...
  5. doi request reprint Memantine in the treatment of binge eating disorder: an open-label, prospective trial
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Int J Eat Disord 41:520-6. 2008
    ..To assess preliminarily the efficacy of memantine in binge eating disorder...
  6. pmc Human growth hormone abuse in male weightlifters
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Am J Addict 20:9-13. 2011
    ..These findings suggest that among young male weightlifters, illicit HGH use has become a common form of substance abuse, frequently associated with both AAS dependence and classical substance dependence. ..
  7. pmc Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    Neuropsychopharmacology 35:834-46. 2010
    ..Further investigation of the Gln/Glu ratio as a possible early biomarker of response to glutamate-modulating therapies is warranted...
  8. ncbi request reprint Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study
    Brian P Brennan
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
    Hum Psychopharmacol 24:423-8. 2009
    ..To assess the efficacy of duloxetine for irritable bowel syndrome (IBS)...
  9. ncbi request reprint Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment
    Harrison G Pope
    Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
    J Clin Psychopharmacol 30:126-34. 2010
    ..The possibility remains that testosterone might benefit a particular subgroup of depressed men, but if so, the characteristics of this subgroup would still need to be established...
  10. doi request reprint Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development
    Andrew A Nierenberg
    Massachusetts General Hospital, Boston, MA 02114, USA
    Aust N Z J Psychiatry 47:26-42. 2013
    ..Based on recent research of the pathophysiology of bipolar disorder, we review the evidence for mitochondrial dysregulation and selected mitochondrial modulators (MM) as potential treatments...